Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Protocol ID
BIOMEDE
Disease (Sub Disease)
Brain and Spinal Tumours
Diagnosis Stage
New diagnosis
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators
Innovative Therapies For Children with Cancer Consortium
Links
Trial Status
Temporarily Closed
Study Type
Treatment
Phase
Phase 2
Age Eligibility
6 months to 25 years
International registry ID's
NCT02233049
| Study Title | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication |
|---|---|
| Protocol ID | BIOMEDE |
| Disease (Sub Disease) | Brain and Spinal Tumours |
| Diagnosis Stage | New diagnosis |
| Sponsor | Gustave Roussy, Cancer Campus, Grand Paris |
| Collaborators | Innovative Therapies For Children with Cancer Consortium |
| Links | https://clinicaltrials.gov/ct2/show/NCT02233049 |
| Trial Status | Temporarily Closed |
| Trial Open Date | 31/07/2018 |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 6 months to 25 years |
| International registry ID's | NCT02233049 |